Search

Search Constraints

You searched for: Author/Creator Westermann, Frank

Search Results

21. Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study. (September 2016)

22. Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma. Issue 2 (21st August 2020)

25. TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets. Issue 1 (December 2018)

27. The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells. (2nd July 2016)

29. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma. Issue 2 (7th November 2015)